Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
Elhassan et al., 2019 | Cell Rep | Rct
Citation
Elhassan Yasir S, Kluckova Katarina, ... Lavery Gareth G. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Rep. 2019-Aug-13;28(7):1717-1728.e6. doi:10.1016/j.celrep.2019.07.043
Abstract
Nicotinamide adenine dinucleotide (NAD+) is modulated by conditions of metabolic stress and has been reported to decline with aging in preclinical models, but human data are sparse. Nicotinamide riboside (NR) supplementation ameliorates metabolic dysfunction in rodents. We aimed to establish whether oral NR supplementation in aged participants can increase the skeletal muscle NAD+ metabolome and if it can alter muscle mitochondrial bioenergetics. We supplemented 12 aged men with 1 g NR per day for 21 days in a placebo-controlled, randomized, double-blind, crossover trial. Targeted metabolomics showed that NR elevated the muscle NAD+ metabolome, evident by increased nicotinic acid adenine dinucleotide and nicotinamide clearance products. Muscle RNA sequencing revealed NR-mediated downregulation of energy metabolism and mitochondria pathways, without altering mitochondrial bioenergetics. NR also depressed levels of circulating inflammatory cytokines. Our data establish that oral NR is available to aged human muscle and identify anti-inflammatory effects of NR.
Key Findings
Our data establish that oral NR is available to aged human muscle and identify anti-inflammatory effects of NR.
Outcomes Measured
- inflammatory markers
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | stress |
MeSH Terms
- Aged
- Aged, 80 and over
- Aging
- Anti-Inflammatory Agents
- Cross-Sectional Studies
- Cytokines
- Double-Blind Method
- Humans
- Male
- Metabolome
- Muscle, Skeletal
- NAD
- Niacinamide
- Pyridinium Compounds
- Transcriptome
Evidence Classification
- Level: Rct
- Publication Types: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Vertical: nicotinamide-riboside
Provenance
- PMID: 31412242
- DOI: 10.1016/j.celrep.2019.07.043
- PMCID: PMC6702140
- Verified: 2026-04-10 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-10